COMPANY

Plumeria Therapeutics, Inc.

HQ: Union, NJ source

Keywords: diagnostics neuropathic pain

Location: Union, NJ · source · Oct 16, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.5M (SBIR Phase II 5R44NS120617-03, continuation, notice May 26, 2026). NIH RePORTER 5R44NS120617-03 (May 26, 2026)
Evidence (1 event)
- May 26, 2026 · NIH RePORTER 5R44NS120617-03
  Organization: PLUMERIA THERAPEUTICS, INC.; City/State: Plainsboro, NJ; Project number: 5R44NS120617-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-26; FY total cost (award amount): 1499999; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Laboratory Developed Test (LDT) to Support Clinical Evaluation of a Drug for Painful Diabetic Neuropathy; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals